United States Gastrointestinal Drugs Market Report 2017

December 2017 | 101 pages | ID: UEA2DAC0630EN
QYResearch

Abstracts

In this report, the United States Gastrointestinal Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Gastrointestinal Drugs in these regions, from 2012 to 2022 (forecast).

United States Gastrointestinal Drugs market competition by top manufacturers/players, with Gastrointestinal Drugs sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• AstraZeneca
• Johnson & Johnson
• Salix Pharma
• Takeda Pharma
• Eisai
• Shire
• Allergan

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Capsules
• Inhalants
• Parenterals
• Tablets
• Other

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Antacid & Anti-Ulcerant
• GIT Anti-inflammatory
• Antiemetic
• Anti-diarrhoea
• Other

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Gastrointestinal Drugs Market Report 2017

1 GASTROINTESTINAL DRUGS OVERVIEW

1.1 Product Overview and Scope of Gastrointestinal Drugs
1.2 Classification of Gastrointestinal Drugs by Product Category
  1.2.1 United States Gastrointestinal Drugs Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Gastrointestinal Drugs Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Capsules
  1.2.4 Inhalants
  1.2.5 Parenterals
  1.2.6 Tablets
  1.2.7 Other
1.3 United States Gastrointestinal Drugs Market by Application/End Users
  1.3.1 United States Gastrointestinal Drugs Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Antacid & Anti-Ulcerant
  1.3.3 GIT Anti-inflammatory
  1.3.4 Antiemetic
  1.3.5 Anti-diarrhoea
  1.3.6 Other
1.4 United States Gastrointestinal Drugs Market by Region
  1.4.1 United States Gastrointestinal Drugs Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Gastrointestinal Drugs Status and Prospect (2012-2022)
  1.4.3 Southwest Gastrointestinal Drugs Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Gastrointestinal Drugs Status and Prospect (2012-2022)
  1.4.5 New England Gastrointestinal Drugs Status and Prospect (2012-2022)
  1.4.6 The South Gastrointestinal Drugs Status and Prospect (2012-2022)
  1.4.7 The Midwest Gastrointestinal Drugs Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Gastrointestinal Drugs (2012-2022)
  1.5.1 United States Gastrointestinal Drugs Sales and Growth Rate (2012-2022)
  1.5.2 United States Gastrointestinal Drugs Revenue and Growth Rate (2012-2022)

2 UNITED STATES GASTROINTESTINAL DRUGS MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Gastrointestinal Drugs Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Gastrointestinal Drugs Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Gastrointestinal Drugs Average Price by Players/Suppliers (2012-2017)
2.4 United States Gastrointestinal Drugs Market Competitive Situation and Trends
  2.4.1 United States Gastrointestinal Drugs Market Concentration Rate
  2.4.2 United States Gastrointestinal Drugs Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Gastrointestinal Drugs Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES GASTROINTESTINAL DRUGS SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Gastrointestinal Drugs Sales and Market Share by Region (2012-2017)
3.2 United States Gastrointestinal Drugs Revenue and Market Share by Region (2012-2017)
3.3 United States Gastrointestinal Drugs Price by Region (2012-2017)

4 UNITED STATES GASTROINTESTINAL DRUGS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Gastrointestinal Drugs Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Gastrointestinal Drugs Revenue and Market Share by Type (2012-2017)
4.3 United States Gastrointestinal Drugs Price by Type (2012-2017)
4.4 United States Gastrointestinal Drugs Sales Growth Rate by Type (2012-2017)

5 UNITED STATES GASTROINTESTINAL DRUGS SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Gastrointestinal Drugs Sales and Market Share by Application (2012-2017)
5.2 United States Gastrointestinal Drugs Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES GASTROINTESTINAL DRUGS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 AstraZeneca
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Gastrointestinal Drugs Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 AstraZeneca Gastrointestinal Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Johnson & Johnson
  6.2.2 Gastrointestinal Drugs Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Johnson & Johnson Gastrointestinal Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Salix Pharma
  6.3.2 Gastrointestinal Drugs Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Salix Pharma Gastrointestinal Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Takeda Pharma
  6.4.2 Gastrointestinal Drugs Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Takeda Pharma Gastrointestinal Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Eisai
  6.5.2 Gastrointestinal Drugs Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Eisai Gastrointestinal Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Shire
  6.6.2 Gastrointestinal Drugs Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Shire Gastrointestinal Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Allergan
  6.7.2 Gastrointestinal Drugs Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Allergan Gastrointestinal Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview

7 GASTROINTESTINAL DRUGS MANUFACTURING COST ANALYSIS

7.1 Gastrointestinal Drugs Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Gastrointestinal Drugs

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Gastrointestinal Drugs Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Gastrointestinal Drugs Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES GASTROINTESTINAL DRUGS MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Gastrointestinal Drugs Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Gastrointestinal Drugs Sales Volume Forecast by Type (2017-2022)
11.3 United States Gastrointestinal Drugs Sales Volume Forecast by Application (2017-2022)
11.4 United States Gastrointestinal Drugs Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Gastrointestinal Drugs
Figure United States Gastrointestinal Drugs Market Size (Units) by Type (2012-2022)
Figure United States Gastrointestinal Drugs Sales Volume Market Share by Type (Product Category) in 2016
Figure Capsules Product Picture
Figure Inhalants Product Picture
Figure Parenterals Product Picture
Figure Tablets Product Picture
Figure Other Product Picture
Figure United States Gastrointestinal Drugs Market Size (Units) by Application (2012-2022)
Figure United States Sales Market Share of Gastrointestinal Drugs by Application in 2016
Figure Antacid & Anti-Ulcerant Examples
Table Key Downstream Customer in Antacid & Anti-Ulcerant
Figure GIT Anti-inflammatory Examples
Table Key Downstream Customer in GIT Anti-inflammatory
Figure Antiemetic Examples
Table Key Downstream Customer in Antiemetic
Figure Anti-diarrhoea Examples
Table Key Downstream Customer in Anti-diarrhoea
Figure Other Examples
Table Key Downstream Customer in Other
Figure United States Gastrointestinal Drugs Market Size (Million USD) by Region (2012-2022)
Figure The West Gastrointestinal Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Gastrointestinal Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Gastrointestinal Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Gastrointestinal Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Gastrointestinal Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Gastrointestinal Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Gastrointestinal Drugs Sales (Units) and Growth Rate (2012-2022)
Figure United States Gastrointestinal Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Gastrointestinal Drugs Market Major Players Product Sales Volume (Units) (2012-2017)
Table United States Gastrointestinal Drugs Sales (Units) of Key Players/Suppliers (2012-2017)
Table United States Gastrointestinal Drugs Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Gastrointestinal Drugs Sales Share by Players/Suppliers
Figure 2017 United States Gastrointestinal Drugs Sales Share by Players/Suppliers
Figure United States Gastrointestinal Drugs Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Gastrointestinal Drugs Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Gastrointestinal Drugs Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Gastrointestinal Drugs Revenue Share by Players/Suppliers
Figure 2017 United States Gastrointestinal Drugs Revenue Share by Players/Suppliers
Table United States Market Gastrointestinal Drugs Average Price (K USD/Unit) of Key Players/Suppliers (2012-2017)
Figure United States Market Gastrointestinal Drugs Average Price (K USD/Unit) of Key Players/Suppliers in 2016
Figure United States Gastrointestinal Drugs Market Share of Top 3 Players/Suppliers
Figure United States Gastrointestinal Drugs Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Gastrointestinal Drugs Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Gastrointestinal Drugs Product Category
Table United States Gastrointestinal Drugs Sales (Units) by Region (2012-2017)
Table United States Gastrointestinal Drugs Sales Share by Region (2012-2017)
Figure United States Gastrointestinal Drugs Sales Share by Region (2012-2017)
Figure United States Gastrointestinal Drugs Sales Market Share by Region in 2016
Table United States Gastrointestinal Drugs Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Gastrointestinal Drugs Revenue Share by Region (2012-2017)
Figure United States Gastrointestinal Drugs Revenue Market Share by Region (2012-2017)
Figure United States Gastrointestinal Drugs Revenue Market Share by Region in 2016
Table United States Gastrointestinal Drugs Price (K USD/Unit) by Region (2012-2017)
Table United States Gastrointestinal Drugs Sales (Units) by Type (2012-2017)
Table United States Gastrointestinal Drugs Sales Share by Type (2012-2017)
Figure United States Gastrointestinal Drugs Sales Share by Type (2012-2017)
Figure United States Gastrointestinal Drugs Sales Market Share by Type in 2016
Table United States Gastrointestinal Drugs Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Gastrointestinal Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Gastrointestinal Drugs by Type (2012-2017)
Figure Revenue Market Share of Gastrointestinal Drugs by Type in 2016
Table United States Gastrointestinal Drugs Price (K USD/Unit) by Types (2012-2017)
Figure United States Gastrointestinal Drugs Sales Growth Rate by Type (2012-2017)
Table United States Gastrointestinal Drugs Sales (Units) by Application (2012-2017)
Table United States Gastrointestinal Drugs Sales Market Share by Application (2012-2017)
Figure United States Gastrointestinal Drugs Sales Market Share by Application (2012-2017)
Figure United States Gastrointestinal Drugs Sales Market Share by Application in 2016
Table United States Gastrointestinal Drugs Sales Growth Rate by Application (2012-2017)
Figure United States Gastrointestinal Drugs Sales Growth Rate by Application (2012-2017)
Table AstraZeneca Basic Information List
Table AstraZeneca Gastrointestinal Drugs Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure AstraZeneca Gastrointestinal Drugs Sales Growth Rate (2012-2017)
Figure AstraZeneca Gastrointestinal Drugs Sales Market Share in United States (2012-2017)
Figure AstraZeneca Gastrointestinal Drugs Revenue Market Share in United States (2012-2017)
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson Gastrointestinal Drugs Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Johnson & Johnson Gastrointestinal Drugs Sales Growth Rate (2012-2017)
Figure Johnson & Johnson Gastrointestinal Drugs Sales Market Share in United States (2012-2017)
Figure Johnson & Johnson Gastrointestinal Drugs Revenue Market Share in United States (2012-2017)
Table Salix Pharma Basic Information List
Table Salix Pharma Gastrointestinal Drugs Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Salix Pharma Gastrointestinal Drugs Sales Growth Rate (2012-2017)
Figure Salix Pharma Gastrointestinal Drugs Sales Market Share in United States (2012-2017)
Figure Salix Pharma Gastrointestinal Drugs Revenue Market Share in United States (2012-2017)
Table Takeda Pharma Basic Information List
Table Takeda Pharma Gastrointestinal Drugs Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Takeda Pharma Gastrointestinal Drugs Sales Growth Rate (2012-2017)
Figure Takeda Pharma Gastrointestinal Drugs Sales Market Share in United States (2012-2017)
Figure Takeda Pharma Gastrointestinal Drugs Revenue Market Share in United States (2012-2017)
Table Eisai Basic Information List
Table Eisai Gastrointestinal Drugs Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Eisai Gastrointestinal Drugs Sales Growth Rate (2012-2017)
Figure Eisai Gastrointestinal Drugs Sales Market Share in United States (2012-2017)
Figure Eisai Gastrointestinal Drugs Revenue Market Share in United States (2012-2017)
Table Shire Basic Information List
Table Shire Gastrointestinal Drugs Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Shire Gastrointestinal Drugs Sales Growth Rate (2012-2017)
Figure Shire Gastrointestinal Drugs Sales Market Share in United States (2012-2017)
Figure Shire Gastrointestinal Drugs Revenue Market Share in United States (2012-2017)
Table Allergan Basic Information List
Table Allergan Gastrointestinal Drugs Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Allergan Gastrointestinal Drugs Sales Growth Rate (2012-2017)
Figure Allergan Gastrointestinal Drugs Sales Market Share in United States (2012-2017)
Figure Allergan Gastrointestinal Drugs Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Gastrointestinal Drugs
Figure Manufacturing Process Analysis of Gastrointestinal Drugs
Figure Gastrointestinal Drugs Industrial Chain Analysis
Table Raw Materials Sources of Gastrointestinal Drugs Major Players/Suppliers in 2016
Table Major Buyers of Gastrointestinal Drugs
Table Distributors/Traders List
Figure United States Gastrointestinal Drugs Sales Volume (Units) and Growth Rate Forecast (2017-2022)
Figure United States Gastrointestinal Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Gastrointestinal Drugs Price (K USD/Unit) Trend Forecast (2017-2022)
Table United States Gastrointestinal Drugs Sales Volume (Units) Forecast by Type (2017-2022)
Figure United States Gastrointestinal Drugs Sales Volume (Units) Forecast by Type (2017-2022)
Figure United States Gastrointestinal Drugs Sales Volume (Units) Forecast by Type in 2022
Table United States Gastrointestinal Drugs Sales Volume (Units) Forecast by Application (2017-2022)
Figure United States Gastrointestinal Drugs Sales Volume (Units) Forecast by Application (2017-2022)
Figure United States Gastrointestinal Drugs Sales Volume (Units) Forecast by Application in 2022
Table United States Gastrointestinal Drugs Sales Volume (Units) Forecast by Region (2017-2022)
Table United States Gastrointestinal Drugs Sales Volume Share Forecast by Region (2017-2022)
Figure United States Gastrointestinal Drugs Sales Volume Share Forecast by Region (2017-2022)
Figure United States Gastrointestinal Drugs Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources